partnership
Impulse Space Wins U.S. Space Force NSSL Phase 3 Contract, Becomes First Upper-Stage Prime
Impulse Space won a U.S. Space Force NSSL Phase 3 contract, becoming the first upper-stage prime contractor.
Markets open original ↗
Importance is a model-assigned 1–5 on published stories, not a market forecast.
Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.
An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.
Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.
Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.
A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.
Tue · 13 Oct · today
Wed · 14 Oct
Thu · 9 Jul
partnership
Impulse Space won a U.S. Space Force NSSL Phase 3 contract, becoming the first upper-stage prime contractor.
Markets open original ↗
partnership
Catalent announced plans to divest one of its UK manufacturing sites.
Markets open original ↗
product
Exelixis' STELLAR-303 trial produced mixed results, while STELLAR-304 success is considered likely.
Markets open original ↗
partnership
Rheinmetall won a contract to develop a laser weapon system for the German Navy.
Markets open original ↗
earnings
Relay Therapeutics missed Q1 2026 EPS estimates as the pre-revenue biotech continues heavy R&D investment.
Markets open original ↗